Physician profile
Tina Doretti
NPI 1750912770
$4,547.84
in general payments reported to CMS, 2019-2025
17 companies · $2,239 in 2025
The $2,239 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $460 · 2022: $751 · 2023: $367 · 2024: $730 · 2025: $2,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,415 · Travel and Lodging: $645 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,415.35 |
| Travel and Lodging | $644.63 |
| Education | $276.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $1,129.99 | 2025 | Remede System |
| Harmony Biosciences LLC | $658.22 | 2024-2025 | |
| Abbvie INC. | $598.72 | 2021-2024 | |
| Jazz Pharmaceuticals INC. | $576.08 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $491.86 | 2024-2025 | Lumryz |
| Lilly USA, LLC | $311.28 | 2021-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.86 | 2021-2022 | |
| Novo Nordisk INC | $181.29 | 2021-2023 | Rybelsus, Ozempic |
| Amgen INC. | $95.10 | 2021-2023 | Evenity, Prolia |
| Axsome Therapeutics, INC. | $76.55 | 2025 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $75.94 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $39.64 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $30.44 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.83 | 2023 | Trulance |
| Fisher & Paykel Healthcare INC | $20.02 | 2025 | Fisher & Paykel Healthcare |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evoke Pharma, INC. | $19.30 | 2023 | Gimoti |
| Medtronic, INC. | $17.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Doretti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.